Canada markets open in 8 hours 51 minutes

Talis Biomedical Corporation (TLIS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
9.19+0.36 (+4.14%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
348
412
3,652
0
0
Cost of Revenue
27
41
8,391
0
-
Gross Profit
321
371
-4,739
0
-
Operating Expenses
Research Development
29,431
40,694
70,831
157,591
89,019
Selling General and Administrative
33,466
28,214
40,729
42,418
13,103
Total Operating Expenses
62,256
67,186
110,400
191,816
91,184
Operating Income or Loss
-61,935
-66,815
-115,139
-191,816
-91,184
Total Other Income/Expenses Net
4,724
4,808
2,127
-220
54
Income Before Tax
-57,211
-62,007
-113,012
-192,036
-91,130
Income from Continuing Operations
-57,211
-62,007
-113,012
-192,036
-91,130
Net Income
-57,211
-62,007
-113,012
-192,036
-91,130
Net Income available to common shareholders
-57,211
-62,007
-113,012
-192,036
-91,130
Basic EPS
-42.42
-34.12
-62.77
-109.08
-69.46
Diluted EPS
-42.42
-34.12
-62.77
-109.08
-69.46
Basic Average Shares
1,790
1,818
1,800
1,761
1,312
Diluted Average Shares
1,790
1,818
1,800
1,761
1,312